Steven Shallcross | executive |
James Molloy | analyst |
Manel Cascalló | executive |
Michael Kaleko | executive |
Greetings. Welcome to Theriva Biologics 2022 full year operational highlights and financial results conference call. [Operator Instructions] Please note, this conference is being recorded.
I will now turn the conference over to Chris Calabrese with LifeSci Advisors.